All press is good press: The Tipline for 26 October 2021

DaVita is doing its part to make sure the technology sector does not steal all the antitrust headlines. This summer, the kidney dialysis company became one of the first defendants ever to face criminal no-poach charges in the US. Now it is the first to try out the Federal Trade Commission’s new stance on prior approvals.

Get unlimited access to all Global Competition Review content